The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.DN-d7ZPu.js ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

With a focus on healthy living and information on advances in breast cancer treatment, Mayo Clinic is holding an educational event at Donna Marathon.

The lower-house National Assembly approved a bill for social security to take on more of the cost of care associated with ...